BSE Live
Apr 21, 11:08Prev. Close
299.00
Open Price
294.50
Bid Price (Qty.)
300.00 (1)
Offer Price (Qty.)
300.55 (69)
NSE Live
Apr 21, 11:08Prev. Close
298.85
Open Price
300.00
Bid Price (Qty.)
300.05 (100)
Offer Price (Qty.)
300.40 (22)
| Cash Flow of Advanced Enzyme Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 187.36 | 187.82 | 140.39 | 171.06 | 210.37 | |
| Net CashFlow From Operating Activities | 142.50 | 141.37 | 140.36 | 122.29 | 162.89 | |
| Net Cash Used In Investing Activities | -89.10 | -64.65 | -298.18 | -24.91 | -26.03 | |
| Net Cash Used From Financing Activities | -72.54 | -59.24 | -25.80 | -27.38 | -26.31 | |
| Foreign Exchange Gains / Losses | -0.38 | -0.15 | 12.66 | 5.43 | -1.90 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.02 | 0.00 | 0.60 | |
| Net Inc/Dec In Cash And Cash Equivalents | -19.53 | 17.33 | -170.94 | 75.44 | 109.26 | |
| Cash And Cash Equivalents Begin of Year | 113.75 | 96.42 | 267.36 | 191.92 | 82.66 | |
| Cash And Cash Equivalents End Of Year | 94.23 | 113.75 | 96.42 | 267.36 | 191.92 |
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth